News|Videos|February 9, 2021

New Treatment Can Help Patients Living with Amyloid Light Chain Amyloidosis

Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic his recent CAEL-101 findings, and how it can help shape treatment for patients living with amyloid light chain amyloidosis.

Pharmacy Times^® interviewed Jason Valent, MD, of the Cleveland Clinic his recent CAEL-101 findings, and how it can help shape treatment for patients living with amyloid light chain amyloidosis. His research surrounding the therapy was presented at the 62^nd American Society of Hematology Annual Meeting & Exposition.

The full conversation can be found in the video above.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

0.5 Credit / Immunology

New Treatment Can Help Patients Living with Amyloid Light Chain Amyloidosis

Newsletter

Related Content

Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment

Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel

Ultraprecision Targeting of CALR Mutations Signals a New Era in Myelofibrosis Treatment

Adolescent, Young Adult Cancer Survivors Experience Accelerated Aging in the Brain

Improving Tolerability and Quality of Life in Pancreatic Cancer Treatment with Atebimetinib

Latest CME

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

Navigating Diabetes: A Guide to Effective Oral Treatments

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

APhA 2026

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

Advancing AML Care: Equipping Pharmacists to Implement Menin Inhibitor Therapies with Precision

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Hyperlipidemia Overview and the Clinical and Economic Burden

The Role of the Pharmacist in the Management of Hyperlipidemia

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Trending on Pharmacy Times

Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments

TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs

Q&A: Making Plant-Based Eating Practical in Pharmacy-Led Cardiometabolic Care

Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment

SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury